Atrophoderma
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Atrophoderma | |
|---|---|
| File:Steroid Atrophy Hands.png | |
| Synonyms | Atrophoderma of Pasini and Pierini |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Thinning of the skin, loss of skin elasticity |
| Complications | Scleroderma, Morphea |
| Onset | Typically in adolescence or early adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly autoimmune |
| Risks | Family history, autoimmune disease |
| Diagnosis | Clinical examination, skin biopsy |
| Differential diagnosis | Morphea, Lichen sclerosus, Anetoderma |
| Prevention | N/A |
| Treatment | Topical corticosteroids, Phototherapy, Immunosuppressive drugs |
| Medication | N/A |
| Prognosis | Variable, may stabilize or progress |
| Frequency | Rare |
| Deaths | N/A |
Atrophoderma is a term used to describe a group of skin conditions characterized by localized or diffuse thinning of the skin. This condition can result from a variety of causes, including genetic factors, inflammatory processes, or the use of certain medications such as corticosteroids.
Etiology[edit]
Atrophoderma can be classified based on its underlying cause:
- Atrophoderma of Pasini and Pierini: A form of atrophoderma that presents as hyperpigmented, depressed patches on the skin, often on the trunk.
- Steroid-induced atrophy: Prolonged use of topical or systemic corticosteroids can lead to thinning of the skin, known as steroid atrophy.
- Anetoderma: Characterized by localized areas of slack skin due to loss of elastic tissue.
Clinical Presentation[edit]
The clinical features of atrophoderma vary depending on the specific type and cause. Common features include:
- Thinning of the skin
- Depressed or indented patches
- Changes in skin pigmentation
Diagnosis[edit]
Diagnosis of atrophoderma is primarily clinical, based on the appearance of the skin. A skin biopsy may be performed to confirm the diagnosis and rule out other conditions.
Management[edit]
Management of atrophoderma depends on the underlying cause. For steroid-induced atrophy, discontinuation or reduction of corticosteroid use is recommended. Other treatments may include:
Prognosis[edit]
The prognosis for atrophoderma varies. Some forms, such as steroid-induced atrophy, may improve with treatment, while others may persist or progress.
